&Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
&Partners's AMGN Position: Q1 2026 in Review
&Partners increased its Amgen (AMGN) stake by 0.17% in Q1 2026, buying an estimated $165K and bringing the position to 280,032 shares worth $98.6M. The position accounts for 0.49% of the portfolio, ranked #35.
&Partners first reported a position in AMGN in Q2 2020 and has held it in 23 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- &Partners held 280,032 shares of Amgen worth $98.6M as of Q1 2026.
- &Partners bought 463 Amgen shares in Q1 2026, an estimated $165K.
- Amgen made up 0.49% of &Partners's portfolio in Q1 2026, its #35 holding.
- &Partners first reported a position in Amgen in Q2 2020 and has held it in 23 quarters since.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.